

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.37696357 |
| 2 | muscle filament sliding (GO:0030049) | 7.96251381 |
| 3 | actin-myosin filament sliding (GO:0033275) | 7.96251381 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.34433084 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 7.18399264 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.08974280 |
| 7 | myofibril assembly (GO:0030239) | 6.92795784 |
| 8 | cardiac myofibril assembly (GO:0055003) | 6.87107130 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.53845653 |
| 10 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.34884681 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.32998171 |
| 12 | actin-mediated cell contraction (GO:0070252) | 6.32514291 |
| 13 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.02686497 |
| 14 | cardiac muscle contraction (GO:0060048) | 5.94829803 |
| 15 | plasma membrane repair (GO:0001778) | 5.86521747 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 5.67670597 |
| 17 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.64404157 |
| 18 | striated muscle contraction (GO:0006941) | 5.58481134 |
| 19 | carnitine shuttle (GO:0006853) | 5.57388295 |
| 20 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.49122897 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 5.38166153 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.37860613 |
| 23 | skeletal muscle contraction (GO:0003009) | 5.35447554 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.21763029 |
| 25 | cardiac muscle cell development (GO:0055013) | 5.19137583 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.18729959 |
| 27 | regulation of coenzyme metabolic process (GO:0051196) | 5.01853985 |
| 28 | regulation of cofactor metabolic process (GO:0051193) | 5.01853985 |
| 29 | actomyosin structure organization (GO:0031032) | 5.01241176 |
| 30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.85534781 |
| 31 | carnitine transmembrane transport (GO:1902603) | 4.83932236 |
| 32 | heart process (GO:0003015) | 4.83778567 |
| 33 | heart contraction (GO:0060047) | 4.83778567 |
| 34 | NADH metabolic process (GO:0006734) | 4.82770176 |
| 35 | cardiac cell development (GO:0055006) | 4.81755289 |
| 36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.76215363 |
| 37 | skeletal muscle adaptation (GO:0043501) | 4.74089896 |
| 38 | creatine metabolic process (GO:0006600) | 4.69434340 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 4.69325018 |
| 40 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.62996391 |
| 41 | actin filament-based movement (GO:0030048) | 4.59441744 |
| 42 | regulation of platelet aggregation (GO:0090330) | 4.56290025 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.49715790 |
| 44 | amino-acid betaine transport (GO:0015838) | 4.46780842 |
| 45 | carnitine transport (GO:0015879) | 4.46780842 |
| 46 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.41972862 |
| 47 | cardiac muscle hypertrophy (GO:0003300) | 4.41531241 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.39943144 |
| 49 | regulation of striated muscle contraction (GO:0006942) | 4.39366920 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.37975147 |
| 51 | neuronal action potential propagation (GO:0019227) | 4.36832052 |
| 52 | succinate metabolic process (GO:0006105) | 4.36481262 |
| 53 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.36022051 |
| 54 | oxidative phosphorylation (GO:0006119) | 4.34930683 |
| 55 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.34782585 |
| 56 | regulation of sarcomere organization (GO:0060297) | 4.28843859 |
| 57 | striated muscle hypertrophy (GO:0014897) | 4.28678013 |
| 58 | adult heart development (GO:0007512) | 4.26439971 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.25456584 |
| 60 | negative regulation of heart rate (GO:0010459) | 4.17562635 |
| 61 | regulation of sequestering of triglyceride (GO:0010889) | 4.14060284 |
| 62 | desmosome organization (GO:0002934) | 4.09599546 |
| 63 | respiratory electron transport chain (GO:0022904) | 4.08770056 |
| 64 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 4.06408463 |
| 65 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 4.06408463 |
| 66 | glycogen catabolic process (GO:0005980) | 4.00856203 |
| 67 | ATP synthesis coupled proton transport (GO:0015986) | 3.99698513 |
| 68 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.99698513 |
| 69 | oxaloacetate metabolic process (GO:0006107) | 3.99390714 |
| 70 | electron transport chain (GO:0022900) | 3.97756099 |
| 71 | muscle tissue morphogenesis (GO:0060415) | 3.97412372 |
| 72 | response to muscle activity (GO:0014850) | 3.95027686 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 3.94999397 |
| 74 | muscle hypertrophy (GO:0014896) | 3.92275095 |
| 75 | regulation of sulfur metabolic process (GO:0042762) | 3.91894035 |
| 76 | oxygen transport (GO:0015671) | 3.88292414 |
| 77 | adenosine receptor signaling pathway (GO:0001973) | 3.86094570 |
| 78 | muscle contraction (GO:0006936) | 3.84744552 |
| 79 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.82522294 |
| 80 | regulation of platelet activation (GO:0010543) | 3.82136320 |
| 81 | response to inactivity (GO:0014854) | 3.80540113 |
| 82 | negative regulation of heart contraction (GO:0045822) | 3.80538691 |
| 83 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.80234117 |
| 84 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.78346924 |
| 85 | protein neddylation (GO:0045116) | 3.76150678 |
| 86 | heart trabecula formation (GO:0060347) | 3.75726372 |
| 87 | glucan catabolic process (GO:0009251) | 3.71999768 |
| 88 | relaxation of muscle (GO:0090075) | 3.71922399 |
| 89 | skeletal muscle fiber development (GO:0048741) | 3.67702960 |
| 90 | striated muscle adaptation (GO:0014888) | 3.66403389 |
| 91 | thrombin receptor signaling pathway (GO:0070493) | 3.63071503 |
| 92 | neutrophil activation involved in immune response (GO:0002283) | 3.62806821 |
| 93 | regulation of membrane repolarization (GO:0060306) | 3.61012385 |
| 94 | regulation of the force of heart contraction (GO:0002026) | 3.60486136 |
| 95 | negative regulation of muscle contraction (GO:0045932) | 3.56046958 |
| 96 | muscle system process (GO:0003012) | 3.54875360 |
| 97 | striated muscle cell development (GO:0055002) | 3.54066280 |
| 98 | striated muscle atrophy (GO:0014891) | 3.51828706 |
| 99 | polysaccharide catabolic process (GO:0000272) | 3.51550126 |
| 100 | quinone biosynthetic process (GO:1901663) | 3.50490010 |
| 101 | ubiquinone biosynthetic process (GO:0006744) | 3.50490010 |
| 102 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.48669885 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.46796656 |
| 104 | cell communication involved in cardiac conduction (GO:0086065) | 3.46723949 |
| 105 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.46104945 |
| 106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.44992716 |
| 107 | cellular polysaccharide catabolic process (GO:0044247) | 3.44937468 |
| 108 | regulation of ATP catabolic process (GO:1903289) | 3.42258948 |
| 109 | regulation of ATPase activity (GO:0043462) | 3.42258948 |
| 110 | negative regulation of potassium ion transport (GO:0043267) | 3.42084324 |
| 111 | skeletal muscle tissue regeneration (GO:0043403) | 3.41873544 |
| 112 | myotube cell development (GO:0014904) | 3.38032862 |
| 113 | negative regulation of protein localization to cell surface (GO:2000009) | 3.36245112 |
| 114 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.35552657 |
| 115 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.35552657 |
| 116 | cell wall macromolecule catabolic process (GO:0016998) | 3.34566946 |
| 117 | cell wall macromolecule metabolic process (GO:0044036) | 3.34566946 |
| 118 | regulation of lipoprotein metabolic process (GO:0050746) | 3.31834667 |
| 119 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31590366 |
| 120 | glucan biosynthetic process (GO:0009250) | 3.31587206 |
| 121 | glycogen biosynthetic process (GO:0005978) | 3.31587206 |
| 122 | positive regulation of cation channel activity (GO:2001259) | 3.30819073 |
| 123 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.27782842 |
| 124 | quaternary ammonium group transport (GO:0015697) | 3.27145083 |
| 125 | negative regulation of platelet activation (GO:0010544) | 3.26923738 |
| 126 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.25576396 |
| 127 | negative regulation of blood circulation (GO:1903523) | 3.17324604 |
| 128 | platelet aggregation (GO:0070527) | 3.15591205 |
| 129 | activation of protein kinase A activity (GO:0034199) | 3.12585364 |
| 130 | negative regulation of norepinephrine secretion (GO:0010700) | 3.11561043 |
| 131 | negative regulation of response to food (GO:0032096) | 2.97262121 |
| 132 | negative regulation of appetite (GO:0032099) | 2.97262121 |
| 133 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.94710621 |
| 134 | relaxation of cardiac muscle (GO:0055119) | 2.91449662 |
| 135 | relaxation of smooth muscle (GO:0044557) | 2.90745790 |
| 136 | muscle fiber development (GO:0048747) | 2.89242390 |
| 137 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.87591119 |
| 138 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86615701 |
| 139 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.85572370 |
| 140 | cellular response to epinephrine stimulus (GO:0071872) | 2.83622675 |
| 141 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.83393135 |
| 142 | regulation of cation channel activity (GO:2001257) | 2.82520115 |
| 143 | cerebellar granule cell differentiation (GO:0021707) | 2.81154344 |
| 144 | negative regulation of cation channel activity (GO:2001258) | 2.77830273 |
| 145 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.77738779 |
| 146 | muscle hypertrophy in response to stress (GO:0003299) | 2.77738779 |
| 147 | cardiac muscle adaptation (GO:0014887) | 2.77738779 |
| 148 | membrane depolarization during action potential (GO:0086010) | 2.77552691 |
| 149 | response to epinephrine (GO:0071871) | 2.75549954 |
| 150 | platelet degranulation (GO:0002576) | 2.75179997 |
| 151 | positive regulation of myoblast differentiation (GO:0045663) | 2.74237754 |
| 152 | cell communication by electrical coupling (GO:0010644) | 2.72072566 |
| 153 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.71152401 |
| 154 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.70207394 |
| 155 | regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 2.64199029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.29344461 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.44220345 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.92331803 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.68780234 |
| 5 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.48176310 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.40018804 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.40018804 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.26085902 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.05308875 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.02915783 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.84247535 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.82297199 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.72605911 |
| 14 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.07321404 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05714309 |
| 16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.00497613 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94491152 |
| 18 | GATA1_19941826_ChIP-Seq_K562_Human | 1.94259325 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90376668 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86761673 |
| 21 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85379192 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83225400 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.80272957 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79921470 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67000465 |
| 26 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.66711256 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62814103 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61178238 |
| 29 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.60356786 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59205567 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58151568 |
| 32 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.57535712 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55460742 |
| 34 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51722028 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49901309 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49009167 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.49008883 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45672330 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45102039 |
| 40 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.44489226 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43944792 |
| 42 | * P68_20966046_ChIP-Seq_HELA_Human | 1.43932744 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43890056 |
| 44 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43095839 |
| 45 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40762044 |
| 46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40676448 |
| 47 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.40291716 |
| 48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.38572948 |
| 49 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.37955431 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34688551 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34106616 |
| 52 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.33968311 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32281548 |
| 54 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.32185801 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30169972 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30134904 |
| 57 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.29276442 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29232460 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28882639 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28171426 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27554413 |
| 62 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.27390296 |
| 63 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.26867457 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26735791 |
| 65 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.26297804 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25719443 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24815528 |
| 68 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.21104704 |
| 69 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20883617 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19107762 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18602111 |
| 72 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17984255 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17945468 |
| 74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16946347 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16465852 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15405207 |
| 77 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14429859 |
| 78 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13692388 |
| 79 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11397531 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10681327 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08880031 |
| 82 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.08684360 |
| 83 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08385202 |
| 84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08375472 |
| 85 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07834570 |
| 86 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07642041 |
| 87 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.07473501 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05589752 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04086817 |
| 90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03767404 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03227609 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03144056 |
| 93 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.01631338 |
| 94 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.01507746 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98724054 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98562790 |
| 97 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98123717 |
| 98 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96810388 |
| 99 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.96543717 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96303115 |
| 101 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95788727 |
| 102 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.95694276 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94963162 |
| 104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94316115 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93870129 |
| 106 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.93193467 |
| 107 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92870029 |
| 108 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92870029 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92713669 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92523840 |
| 111 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.91327923 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90751083 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90744720 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90596728 |
| 115 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90024332 |
| 116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89814041 |
| 117 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.89595691 |
| 118 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89156077 |
| 119 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89006800 |
| 120 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88594533 |
| 121 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.88585956 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88239829 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87554919 |
| 124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87031847 |
| 125 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.86731456 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85869281 |
| 127 | MAF_26560356_Chip-Seq_TH1_Human | 0.85277875 |
| 128 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84885915 |
| 129 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84414096 |
| 130 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84040792 |
| 131 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.83952558 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83888006 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83297589 |
| 134 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82434546 |
| 135 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82249291 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82056046 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81998898 |
| 138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81975537 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81730358 |
| 140 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.81050232 |
| 141 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80114536 |
| 142 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79933864 |
| 143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79799952 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79799952 |
| 145 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.79359197 |
| 146 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.79055696 |
| 147 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79026396 |
| 148 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.77634439 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77144136 |
| 150 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76979714 |
| 151 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.76249112 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75186791 |
| 153 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.73312502 |
| 154 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.72460079 |
| 155 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.71349713 |
| 156 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.69626085 |
| 157 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69505050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 7.06827421 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.42539762 |
| 3 | MP0000751_myopathy | 5.30997992 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.67341127 |
| 5 | MP0005464_abnormal_platelet_physiology | 4.65944209 |
| 6 | MP0000749_muscle_degeneration | 4.42524766 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.34147385 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.99068885 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.64818360 |
| 10 | MP0005330_cardiomyopathy | 3.34124787 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.11463886 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.96792013 |
| 13 | MP0004130_abnormal_muscle_cell | 2.91175750 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.72821105 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.71828390 |
| 16 | MP0008004_abnormal_stomach_pH | 2.67663556 |
| 17 | MP0002269_muscular_atrophy | 2.63993676 |
| 18 | MP0002972_abnormal_cardiac_muscle | 2.56132190 |
| 19 | MP0000747_muscle_weakness | 2.44848651 |
| 20 | MP0005369_muscle_phenotype | 2.37445467 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.37309675 |
| 22 | MP0000759_abnormal_skeletal_muscle | 2.37162875 |
| 23 | MP0004484_altered_response_of | 2.27108921 |
| 24 | MP0003879_abnormal_hair_cell | 2.24872982 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 2.23979907 |
| 26 | MP0003137_abnormal_impulse_conducting | 2.16790575 |
| 27 | MP0010630_abnormal_cardiac_muscle | 2.15212571 |
| 28 | MP0005385_cardiovascular_system_phenoty | 2.14686967 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 2.14686967 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 2.05264514 |
| 31 | MP0004233_abnormal_muscle_weight | 2.03930337 |
| 32 | MP0005410_abnormal_fertilization | 1.96734896 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.87796171 |
| 34 | MP0004270_analgesia | 1.87457730 |
| 35 | MP0006138_congestive_heart_failure | 1.80210211 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.73067104 |
| 37 | MP0003724_increased_susceptibility_to | 1.63777960 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.59441674 |
| 39 | MP0003828_pulmonary_edema | 1.57873440 |
| 40 | MP0004085_abnormal_heartbeat | 1.57432461 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.54877290 |
| 42 | MP0005670_abnormal_white_adipose | 1.52184739 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.48423046 |
| 44 | MP0004510_myositis | 1.48193144 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.43549442 |
| 46 | MP0000343_altered_response_to | 1.40502210 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.39260091 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.38202938 |
| 49 | MP0002736_abnormal_nociception_after | 1.37608631 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.33020840 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.29689472 |
| 52 | MP0002064_seizures | 1.20158128 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.19656449 |
| 54 | MP0003303_peritoneal_inflammation | 1.15492642 |
| 55 | MP0002796_impaired_skin_barrier | 1.13834846 |
| 56 | MP0002272_abnormal_nervous_system | 1.12364283 |
| 57 | MP0004147_increased_porphyrin_level | 1.07762187 |
| 58 | MP0008872_abnormal_physiological_respon | 1.07222609 |
| 59 | MP0009745_abnormal_behavioral_response | 1.05550604 |
| 60 | MP0003638_abnormal_response/metabolism_ | 1.03630774 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.03424344 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.03046542 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.02388813 |
| 64 | MP0002734_abnormal_mechanical_nocicepti | 1.02373654 |
| 65 | MP0005275_abnormal_skin_tensile | 1.01857447 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.01129620 |
| 67 | MP0009046_muscle_twitch | 1.00376580 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.00001547 |
| 69 | MP0005646_abnormal_pituitary_gland | 0.98534850 |
| 70 | MP0005266_abnormal_metabolism | 0.96406009 |
| 71 | MP0001486_abnormal_startle_reflex | 0.96365279 |
| 72 | MP0002735_abnormal_chemical_nociception | 0.95553328 |
| 73 | MP0002108_abnormal_muscle_morphology | 0.93396219 |
| 74 | MP0001970_abnormal_pain_threshold | 0.93044533 |
| 75 | MP0002971_abnormal_brown_adipose | 0.91771605 |
| 76 | MP0002067_abnormal_sensory_capabilities | 0.87794588 |
| 77 | MP0003880_abnormal_central_pattern | 0.87202946 |
| 78 | MP0005165_increased_susceptibility_to | 0.86778692 |
| 79 | MP0002063_abnormal_learning/memory/cond | 0.83534212 |
| 80 | MP0000579_abnormal_nail_morphology | 0.83380929 |
| 81 | MP0000266_abnormal_heart_morphology | 0.82443807 |
| 82 | MP0006276_abnormal_autonomic_nervous | 0.78364852 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.75225508 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.73242152 |
| 85 | MP0002822_catalepsy | 0.70761036 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68888717 |
| 87 | MP0001851_eye_inflammation | 0.68669756 |
| 88 | MP0005451_abnormal_body_composition | 0.68139038 |
| 89 | MP0004142_abnormal_muscle_tone | 0.67612830 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 0.67530044 |
| 91 | MP0003045_fibrosis | 0.67097438 |
| 92 | MP0001853_heart_inflammation | 0.66987376 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.65899696 |
| 94 | MP0000733_abnormal_muscle_development | 0.64859866 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.63953779 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.63486110 |
| 97 | MP0004043_abnormal_pH_regulation | 0.63216716 |
| 98 | MP0005166_decreased_susceptibility_to | 0.60797147 |
| 99 | MP0003075_altered_response_to | 0.59780838 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.58452194 |
| 101 | MP0003806_abnormal_nucleotide_metabolis | 0.57585448 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.57013251 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.56222710 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.54015344 |
| 105 | MP0002066_abnormal_motor_capabilities/c | 0.53998071 |
| 106 | MP0005501_abnormal_skin_physiology | 0.50598709 |
| 107 | MP0002128_abnormal_blood_circulation | 0.50539065 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.49862653 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.48836445 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.47525548 |
| 111 | MP0008569_lethality_at_weaning | 0.47407601 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.47278296 |
| 113 | MP0005535_abnormal_body_temperature | 0.44413996 |
| 114 | MP0003698_abnormal_male_reproductive | 0.44269006 |
| 115 | MP0005334_abnormal_fat_pad | 0.40355556 |
| 116 | MP0009115_abnormal_fat_cell | 0.40308052 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40085616 |
| 118 | MP0003279_aneurysm | 0.38881878 |
| 119 | MP0003191_abnormal_cellular_cholesterol | 0.37193792 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.35121811 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.35053204 |
| 122 | MP0002970_abnormal_white_adipose | 0.34785828 |
| 123 | MP0008874_decreased_physiological_sensi | 0.31483452 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.30249701 |
| 125 | MP0005083_abnormal_biliary_tract | 0.28811895 |
| 126 | MP0001929_abnormal_gametogenesis | 0.28159630 |
| 127 | MP0005452_abnormal_adipose_tissue | 0.27638306 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.27469376 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.25770152 |
| 130 | MP0002060_abnormal_skin_morphology | 0.24610789 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.24312425 |
| 132 | MP0004808_abnormal_hematopoietic_stem | 0.21989281 |
| 133 | MP0000467_abnormal_esophagus_morphology | 0.21984767 |
| 134 | MP0001784_abnormal_fluid_regulation | 0.21419246 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.20187905 |
| 136 | MP0003948_abnormal_gas_homeostasis | 0.20081072 |
| 137 | MP0000358_abnormal_cell_content/ | 0.19714674 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.18716636 |
| 139 | MP0000249_abnormal_blood_vessel | 0.17818955 |
| 140 | MP0001727_abnormal_embryo_implantation | 0.16337783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.48823218 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.06339221 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.60552487 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.52481615 |
| 5 | Sudden death (HP:0001699) | 6.45343206 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.04409495 |
| 7 | Prolonged bleeding time (HP:0003010) | 5.96204637 |
| 8 | Myoglobinuria (HP:0002913) | 5.76826636 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.57866432 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.41965443 |
| 11 | Menorrhagia (HP:0000132) | 5.33742534 |
| 12 | Increased mean platelet volume (HP:0011877) | 5.10216865 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 4.90084088 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 4.84831525 |
| 15 | Abnormal platelet volume (HP:0011876) | 4.81658466 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.76120611 |
| 17 | Rhabdomyolysis (HP:0003201) | 4.75668565 |
| 18 | Petechiae (HP:0000967) | 4.53175748 |
| 19 | Subaortic stenosis (HP:0001682) | 4.47467623 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.47467623 |
| 21 | Difficulty running (HP:0009046) | 4.46364578 |
| 22 | Atrial fibrillation (HP:0005110) | 4.42260697 |
| 23 | Purpura (HP:0000979) | 4.37789389 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 4.27280216 |
| 25 | Lipoatrophy (HP:0100578) | 4.23218198 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 4.22880083 |
| 27 | Increased connective tissue (HP:0009025) | 4.22015590 |
| 28 | Primary atrial arrhythmia (HP:0001692) | 4.12860147 |
| 29 | Nemaline bodies (HP:0003798) | 4.10486850 |
| 30 | Supraventricular tachycardia (HP:0004755) | 4.03757485 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.95008757 |
| 32 | Bundle branch block (HP:0011710) | 3.93280882 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 3.92763182 |
| 34 | Myotonia (HP:0002486) | 3.80880910 |
| 35 | Palpitations (HP:0001962) | 3.71838057 |
| 36 | Epistaxis (HP:0000421) | 3.68933142 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.65420561 |
| 38 | Dilated cardiomyopathy (HP:0001644) | 3.63998630 |
| 39 | Muscle stiffness (HP:0003552) | 3.62571287 |
| 40 | Type 1 muscle fiber predominance (HP:0003803) | 3.57519737 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.32640108 |
| 42 | Syncope (HP:0001279) | 3.29753717 |
| 43 | Difficulty climbing stairs (HP:0003551) | 3.18303240 |
| 44 | Heart block (HP:0012722) | 3.17823863 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.14275841 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 3.11766239 |
| 47 | Acute necrotizing encephalopathy (HP:0006965) | 3.05406044 |
| 48 | Abnormal atrioventricular conduction (HP:0005150) | 2.99144301 |
| 49 | Ventricular arrhythmia (HP:0004308) | 2.96541559 |
| 50 | Distal arthrogryposis (HP:0005684) | 2.95947042 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.95166517 |
| 52 | Hepatic necrosis (HP:0002605) | 2.94872418 |
| 53 | Myopathic facies (HP:0002058) | 2.89736654 |
| 54 | Neck muscle weakness (HP:0000467) | 2.88336440 |
| 55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.87359051 |
| 56 | Prolonged QT interval (HP:0001657) | 2.84863868 |
| 57 | Ventricular fibrillation (HP:0001663) | 2.82799491 |
| 58 | Gingival bleeding (HP:0000225) | 2.82264977 |
| 59 | Atrioventricular block (HP:0001678) | 2.81254178 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.76839560 |
| 61 | Hepatocellular necrosis (HP:0001404) | 2.70578143 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.69197442 |
| 63 | Impaired platelet aggregation (HP:0003540) | 2.67513478 |
| 64 | Abnormal platelet function (HP:0011869) | 2.67513478 |
| 65 | Paralysis (HP:0003470) | 2.65668244 |
| 66 | Lower limb amyotrophy (HP:0007210) | 2.59941660 |
| 67 | Conjunctival hamartoma (HP:0100780) | 2.59465142 |
| 68 | Round ear (HP:0100830) | 2.58576220 |
| 69 | Acute encephalopathy (HP:0006846) | 2.56421771 |
| 70 | Mitochondrial inheritance (HP:0001427) | 2.53034329 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.51873878 |
| 72 | Increased muscle lipid content (HP:0009058) | 2.51746322 |
| 73 | Palmoplantar keratoderma (HP:0000982) | 2.47564299 |
| 74 | Exercise intolerance (HP:0003546) | 2.43491570 |
| 75 | Rimmed vacuoles (HP:0003805) | 2.42396014 |
| 76 | Abnormal pupillary function (HP:0007686) | 2.40419675 |
| 77 | Increased CSF lactate (HP:0002490) | 2.38202853 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 2.37853856 |
| 79 | Febrile seizures (HP:0002373) | 2.36733428 |
| 80 | Atonic seizures (HP:0010819) | 2.36532144 |
| 81 | Left ventricular hypertrophy (HP:0001712) | 2.31450893 |
| 82 | Facial diplegia (HP:0001349) | 2.30686698 |
| 83 | Cerebral edema (HP:0002181) | 2.23137852 |
| 84 | Fatigable weakness (HP:0003473) | 2.22180180 |
| 85 | Abnormality of the neuromuscular junction (HP:0003398) | 2.22180180 |
| 86 | Abnormal EKG (HP:0003115) | 2.22018592 |
| 87 | Poikilocytosis (HP:0004447) | 2.20911806 |
| 88 | Ketoacidosis (HP:0001993) | 2.20738090 |
| 89 | Lactic acidosis (HP:0003128) | 2.19813660 |
| 90 | Increased intramyocellular lipid droplets (HP:0012240) | 2.19531037 |
| 91 | EMG: neuropathic changes (HP:0003445) | 2.19322422 |
| 92 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17398427 |
| 93 | Esophageal neoplasm (HP:0100751) | 2.15729698 |
| 94 | Neoplasm of head and neck (HP:0012288) | 2.15729698 |
| 95 | Testicular atrophy (HP:0000029) | 2.14883631 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 2.13534007 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13534007 |
| 98 | Muscular dystrophy (HP:0003560) | 2.12874189 |
| 99 | Myokymia (HP:0002411) | 2.09669898 |
| 100 | Absent phalangeal crease (HP:0006109) | 2.08893517 |
| 101 | Dysmetric saccades (HP:0000641) | 2.08322333 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 2.08110311 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 2.07493821 |
| 104 | Calcaneovalgus deformity (HP:0001848) | 2.05754433 |
| 105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.05354708 |
| 106 | Abnormality of alanine metabolism (HP:0010916) | 2.05354708 |
| 107 | Hyperalaninemia (HP:0003348) | 2.05354708 |
| 108 | Generalized muscle weakness (HP:0003324) | 2.04919362 |
| 109 | Progressive muscle weakness (HP:0003323) | 2.02721600 |
| 110 | Respiratory failure (HP:0002878) | 2.02180539 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.00593663 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 2.00072446 |
| 113 | Proximal amyotrophy (HP:0007126) | 1.98935822 |
| 114 | Malignant hyperthermia (HP:0002047) | 1.98274055 |
| 115 | Focal motor seizures (HP:0011153) | 1.96643196 |
| 116 | Frequent falls (HP:0002359) | 1.96610001 |
| 117 | Gowers sign (HP:0003391) | 1.96099942 |
| 118 | Abnormality of binocular vision (HP:0011514) | 1.94540417 |
| 119 | Diplopia (HP:0000651) | 1.94540417 |
| 120 | Ragged-red muscle fibers (HP:0003200) | 1.92395212 |
| 121 | Fetal akinesia sequence (HP:0001989) | 1.90052948 |
| 122 | Visual hallucinations (HP:0002367) | 1.89639606 |
| 123 | Cholelithiasis (HP:0001081) | 1.89636800 |
| 124 | Weak cry (HP:0001612) | 1.87817936 |
| 125 | Bulbar palsy (HP:0001283) | 1.87241980 |
| 126 | Scapular winging (HP:0003691) | 1.86448466 |
| 127 | Ketosis (HP:0001946) | 1.84314919 |
| 128 | Hypoglycemic coma (HP:0001325) | 1.82051237 |
| 129 | Hamartoma of the eye (HP:0010568) | 1.80423644 |
| 130 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.80267884 |
| 131 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.80267884 |
| 132 | Acanthocytosis (HP:0001927) | 1.80175561 |
| 133 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78275970 |
| 134 | Deformed tarsal bones (HP:0008119) | 1.73315290 |
| 135 | Waddling gait (HP:0002515) | 1.73154656 |
| 136 | Ankle clonus (HP:0011448) | 1.73065059 |
| 137 | Nonprogressive disorder (HP:0003680) | 1.67060104 |
| 138 | Slender build (HP:0001533) | 1.66487775 |
| 139 | Tinnitus (HP:0000360) | 1.64409720 |
| 140 | Hyperkalemia (HP:0002153) | 1.64295657 |
| 141 | Abnormal finger flexion creases (HP:0006143) | 1.62068310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.24760575 |
| 2 | PDK3 | 5.19127697 |
| 3 | PDK4 | 5.19127697 |
| 4 | OBSCN | 4.71478141 |
| 5 | PHKG1 | 4.26453855 |
| 6 | PHKG2 | 4.26453855 |
| 7 | RIPK4 | 3.42863279 |
| 8 | PDK2 | 2.99778703 |
| 9 | MYLK | 2.61989752 |
| 10 | LMTK2 | 2.47798631 |
| 11 | NEK1 | 2.45569532 |
| 12 | BCKDK | 2.39854471 |
| 13 | PINK1 | 2.28456895 |
| 14 | TRIB3 | 2.24435109 |
| 15 | DMPK | 2.19499354 |
| 16 | MUSK | 2.13808539 |
| 17 | BMX | 2.04837694 |
| 18 | MAP2K3 | 1.86333080 |
| 19 | NME1 | 1.82216889 |
| 20 | GRK5 | 1.79015799 |
| 21 | DAPK2 | 1.76821201 |
| 22 | PKN2 | 1.75123438 |
| 23 | ARAF | 1.70060383 |
| 24 | MAPKAPK3 | 1.60575254 |
| 25 | PIK3CA | 1.54615977 |
| 26 | STK24 | 1.45036682 |
| 27 | TIE1 | 1.38471637 |
| 28 | MAP3K7 | 1.25468588 |
| 29 | MST4 | 1.24771456 |
| 30 | GRK7 | 1.17869470 |
| 31 | TNK2 | 1.16052860 |
| 32 | PIK3CG | 1.16042227 |
| 33 | MAP3K9 | 1.11120570 |
| 34 | TESK1 | 1.07584596 |
| 35 | MAPK12 | 1.04898071 |
| 36 | EIF2AK1 | 1.03797429 |
| 37 | TRPM7 | 1.01986601 |
| 38 | PLK2 | 0.95492454 |
| 39 | MARK1 | 0.93905616 |
| 40 | ILK | 0.93643354 |
| 41 | MAP2K6 | 0.92184891 |
| 42 | MAP3K5 | 0.87917675 |
| 43 | KSR2 | 0.87097555 |
| 44 | MAP3K3 | 0.85250651 |
| 45 | GRK6 | 0.84101997 |
| 46 | MAP3K12 | 0.82582272 |
| 47 | EEF2K | 0.82570759 |
| 48 | MAP2K1 | 0.81234519 |
| 49 | CSF1R | 0.79944014 |
| 50 | FES | 0.79038700 |
| 51 | ICK | 0.78926937 |
| 52 | NTRK3 | 0.78412585 |
| 53 | MAP2K4 | 0.74001749 |
| 54 | PRKAA1 | 0.73751701 |
| 55 | PAK1 | 0.72448528 |
| 56 | CAMK2D | 0.71509448 |
| 57 | PRKD1 | 0.70610022 |
| 58 | EPHA4 | 0.70504394 |
| 59 | RAF1 | 0.70247303 |
| 60 | MINK1 | 0.69254378 |
| 61 | KDR | 0.68524835 |
| 62 | PRKAA2 | 0.68407844 |
| 63 | UHMK1 | 0.65765184 |
| 64 | CAMK2B | 0.64064302 |
| 65 | RIPK1 | 0.63898277 |
| 66 | MARK3 | 0.63428254 |
| 67 | TAOK2 | 0.62443213 |
| 68 | CCNB1 | 0.62126182 |
| 69 | PRKD3 | 0.61453844 |
| 70 | PAK6 | 0.61088067 |
| 71 | HCK | 0.61023181 |
| 72 | STK4 | 0.60631774 |
| 73 | BMPR2 | 0.60586784 |
| 74 | RPS6KL1 | 0.57301914 |
| 75 | RPS6KC1 | 0.57301914 |
| 76 | MAPK13 | 0.55459950 |
| 77 | SGK2 | 0.54514482 |
| 78 | BLK | 0.54063990 |
| 79 | MAP3K13 | 0.53595963 |
| 80 | TAOK1 | 0.53059589 |
| 81 | SGK3 | 0.52785345 |
| 82 | CAMK4 | 0.52485962 |
| 83 | RPS6KA6 | 0.51075173 |
| 84 | PDK1 | 0.50969097 |
| 85 | FGR | 0.48251437 |
| 86 | ZAK | 0.48211910 |
| 87 | MAP3K11 | 0.46526630 |
| 88 | STK38 | 0.45861423 |
| 89 | NEK9 | 0.45204928 |
| 90 | CAMK1 | 0.44576623 |
| 91 | TAOK3 | 0.43965611 |
| 92 | PTK2B | 0.42909831 |
| 93 | ROCK1 | 0.41168836 |
| 94 | PDPK1 | 0.40329068 |
| 95 | PRPF4B | 0.39643338 |
| 96 | RET | 0.39561954 |
| 97 | WNK4 | 0.39400495 |
| 98 | PRKACB | 0.39283793 |
| 99 | SGK223 | 0.38799586 |
| 100 | SGK494 | 0.38799586 |
| 101 | EPHB1 | 0.38750850 |
| 102 | ERN1 | 0.38309184 |
| 103 | LIMK1 | 0.36639718 |
| 104 | MAP3K6 | 0.36485813 |
| 105 | CDK5 | 0.35127426 |
| 106 | DAPK1 | 0.35069667 |
| 107 | PAK3 | 0.34779697 |
| 108 | SIK1 | 0.32184120 |
| 109 | PRKACA | 0.32121535 |
| 110 | PKN1 | 0.31744188 |
| 111 | DAPK3 | 0.31464800 |
| 112 | PRKACG | 0.31149425 |
| 113 | LRRK2 | 0.30739764 |
| 114 | CAMK2G | 0.30079110 |
| 115 | MAPK11 | 0.29617420 |
| 116 | BTK | 0.29443378 |
| 117 | BRAF | 0.29019181 |
| 118 | MAPK4 | 0.28601957 |
| 119 | FLT3 | 0.27450631 |
| 120 | MARK2 | 0.27360167 |
| 121 | PTK6 | 0.27286287 |
| 122 | IKBKB | 0.27177839 |
| 123 | CAMK2A | 0.26958260 |
| 124 | TGFBR2 | 0.26594243 |
| 125 | JAK1 | 0.26353539 |
| 126 | KIT | 0.25804754 |
| 127 | RPS6KA1 | 0.25483745 |
| 128 | RPS6KB2 | 0.24357816 |
| 129 | TEC | 0.24341362 |
| 130 | AKT2 | 0.23530805 |
| 131 | WNK1 | 0.22838397 |
| 132 | MAP3K1 | 0.22576244 |
| 133 | PIM2 | 0.22196647 |
| 134 | INSRR | 0.21597594 |
| 135 | JAK2 | 0.20143117 |
| 136 | ROCK2 | 0.19963621 |
| 137 | RPS6KA2 | 0.19811732 |
| 138 | SYK | 0.19773462 |
| 139 | NME2 | 0.19306360 |
| 140 | PRKG1 | 0.18382752 |
| 141 | TYK2 | 0.16918968 |
| 142 | ZAP70 | 0.16848463 |
| 143 | CAMKK2 | 0.16563120 |
| 144 | MAPKAPK2 | 0.13605302 |
| 145 | TBK1 | 0.13444529 |
| 146 | DYRK1B | 0.13274676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.29381383 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.17435908 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.98876037 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.45715105 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.30318912 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26792304 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19881439 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.17313642 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.14637572 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.79679248 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67225318 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.45509475 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.32623369 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.23072220 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.19603218 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.16847157 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06701811 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 2.05901407 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77124298 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70753064 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70292848 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.57062081 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.50450607 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.49769739 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.49319977 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46874263 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45115107 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44142408 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39610982 |
| 30 | * Gap junction_Homo sapiens_hsa04540 | 1.37496289 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.36553368 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31732995 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29298444 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27140585 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26659057 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.23513005 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21905738 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21498266 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20728153 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17933658 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.12884389 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12392900 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.11828696 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11255181 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07950654 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07116201 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05035161 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01654194 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94918144 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94814639 |
| 51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.94430308 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93789770 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92374582 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90510972 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87458411 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87410851 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86858178 |
| 58 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85723148 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84882812 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84169545 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83213952 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80475060 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78840644 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78071325 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77791399 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77499444 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74386194 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.72587235 |
| 69 | Nicotine addiction_Homo sapiens_hsa05033 | 0.72301377 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71154753 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.69232831 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.65623284 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64986929 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63259414 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60806675 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.55999630 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53741513 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53510859 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53133861 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49763056 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49479316 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48713225 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.47684296 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47484696 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46334728 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45437176 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45188019 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43407372 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43349552 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.42374419 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42214656 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41045231 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.40312277 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40212749 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38281395 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36325344 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35418984 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34378320 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33431120 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33395349 |
| 101 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32206891 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31505391 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31310005 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31083335 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.29760727 |
| 106 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29662493 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26466240 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23911783 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.20993414 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19126021 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.18506657 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.18137503 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16328167 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.16116344 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.15632242 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15414215 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.13677217 |
| 118 | Insulin secretion_Homo sapiens_hsa04911 | 0.13285101 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.12599218 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11910770 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.09950722 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.09909607 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09862675 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.09397552 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.08515353 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08179191 |
| 127 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07094102 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.06975806 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06492287 |
| 130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.06415411 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06145838 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.05448855 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.05096603 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04667991 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.04199334 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03753887 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02946836 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01405611 |
| 139 | Asthma_Homo sapiens_hsa05310 | -0.0064822 |

